Related Experiment Video
Updated: Jul 9, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Methicillin-resistant Staphylococcus aureus nasal carriage among injection drug users: six years later
G N Al-Rawahi1, A G Schreader, S D Porter
1Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Abstract:
A survey in 2000 to detect methicillin-resistant Staphylococcus aureus (MRSA) colonization in Vancouver downtown east side injection drug users (IDUs) revealed an MRSA nasal colonization incidence of 7.4%. This is a follow-up study to determine the current prevalence of MRSA colonization and to further characterize the isolates and risk factors for colonization. In this point prevalence study of MRSA nasal carriage among IDUs, nasal swabs were cultured to detect S. aureus. Isolates were studied for their antimicrobial susceptibility patterns and the presence of mecA and Panton-Valentine leukocidin (PVL) genes and by pulsed-field gel electrophoresis (PFGE). S. aureus was isolated from 119 of 301 (39.5%) samples; three (2.5%) participants had both methicillin-sensitive S. aureus (MSSA) and MRSA, resulting in 122 isolates. Of these, 54.1% were MSSA and 45.9% were MRSA, with an overall MRSA rate of 18.6%. USA-300 (CMRSA-10) accounted for 75% of all MRSA isolates; 25% were USA-500 (CMRSA-5). None of the USA-500 isolates were positive for PVL; 41 (97.6%) USA-300 isolates contained PVL. One MSSA isolate, from an individual also carrying USA-300, was positive for PVL. The PFGE pattern of this MSSA isolate was related to that of the MRSA strain. The antibiograms of USA-300 compared to USA-500 isolates showed 100% versus 7.1% susceptibility to trimethoprim-sulfamethoxazole (TMP-SMX) and 54.8% versus 7.1% susceptibility to clindamycin. MRSA nasal colonization in this population has increased significantly within the last 6 years, with USA-300 replacing the previous strain. Most of these strains are PVL positive, and all are susceptible to TMP-SMX.
Insights
Methicillin-resistant Staphylococcus aureus (MRSA) nasal colonization significantly increased among injection drug users in Vancouver. The prevalent USA-300 strain is largely Panton-Valentine leukocidin (PVL)-positive and remains susceptible to trimethoprim-sulfamethoxazole (TMP-SMX).
Area of Science:
- Microbiology
- Epidemiology
- Public Health
Background:
- A 2000 survey found 7.4% MRSA nasal colonization in Vancouver injection drug users (IDUs).
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant public health threat, particularly in vulnerable populations.
- Understanding current MRSA prevalence and characteristics in IDUs is crucial for targeted interventions.
Purpose of the Study:
- To determine the current prevalence of MRSA nasal carriage among Vancouver IDUs.
- To characterize MRSA isolates, including antimicrobial susceptibility and virulence factors.
- To identify risk factors associated with MRSA colonization in this population.
Main Methods:
- A point prevalence study involving nasal swab cultures from IDUs.
- Antimicrobial susceptibility testing of isolated Staphylococcus aureus strains.
- Detection of mecA and Panton-Valentine leukocidin (PVL) genes.
- Pulsed-field gel electrophoresis (PFGE) for strain typing.
Main Results:
- Staphylococcus aureus was isolated from 39.5% of participants; 18.6% had MRSA.
- The USA-300 strain (CMRSA-10) predominated (75% of MRSA), replacing USA-500 (CMRSA-5).
- Most USA-300 isolates (97.6%) were PVL-positive, while USA-500 isolates were PVL-negative.
- USA-300 isolates showed higher susceptibility to trimethoprim-sulfamethoxazole (TMP-SMX) (100%) and clindamycin (54.8%) compared to USA-500.
Conclusions:
- MRSA nasal colonization has significantly increased in Vancouver IDUs since 2000.
- The USA-300 strain, often PVL-positive, is now the dominant MRSA strain in this population.
- While MRSA strains remain susceptible to TMP-SMX, the high prevalence of PVL warrants continued surveillance and targeted prevention strategies.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Staphylococcal Skin Infections
Drug Accumulation During Multiple Dosing: Repetitive IV Injections